BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 12352907)

  • 1. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.
    Ciancio G; Burke GW; Garcia-Morales R; Suzart K; Rosen A; Ricordi C; Kenyon NS; Mathew JM; Tzakis AG; Esquenazi V; Miller J
    Transplantation; 2002 Aug; 74(4):488-96. PubMed ID: 12352907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor bone marrow infusion in deceased and living donor renal transplantation.
    Ciancio G; Burke GW; Moon J; Garcia-Morales R; Rosen A; Esquenazi V; Mathew J; Jin Y; Miller J
    Yonsei Med J; 2004 Dec; 45(6):998-1003. PubMed ID: 15627290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-year clinical effect of donor bone marrow infusions in renal transplant patients.
    Ciancio G; Miller J; Garcia-Morales RO; Carreno M; Burke GW; Roth D; Kupin W; Tzakis AG; Ricordi C; Rosen A; Fuller L; Esquenazi V
    Transplantation; 2001 Apr; 71(7):827-35. PubMed ID: 11349712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses.
    Mathew JM; Garcia-Morales R; Fuller L; Rosen A; Ciancio G; Burke GW; Carreno M; Temple D; Tzakis AG; Ricordi C; Miller J; Esquenazi V
    Transplantation; 2000 Dec; 70(12):1675-82. PubMed ID: 11152096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.
    Mathew JM; Garcia-Morales RO; Carreno M; Jin Y; Fuller L; Blomberg B; Cirocco R; Burke GW; Ciancio G; Ricordi C; Esquenazi V; Tzakis AG; Miller J
    Transpl Immunol; 2003; 11(3-4):307-21. PubMed ID: 12967784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusion.
    Cirocco RE; Carreño MR; Mathew JM; Garcia-Morales RO; Fuller L; Esquenazi V; Ciancio G; Burke GW; Gaynor JJ; Blomberg BB; Rosen A; Kleiner G; Ricordi C; Miller J
    Transplantation; 2007 Jun; 83(12):1611-9. PubMed ID: 17589345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival.
    Solgi G; Gadi V; Paul B; Mytilineos J; Pourmand G; Mehrsai A; Ranjbar M; Mohammadnia M; Nikbin B; Amirzargar AA
    Chimerism; 2013; 4(3):87-94. PubMed ID: 23639966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry.
    Garcia-Morales R; Esquenazi V; Zucker K; Gomez CI; Fuller L; Carreno M; Cirocco R; Alamo A; Karatzas T; Burke GW; Ciancio G; Temple D; Fernandez H; Ricordi C; Tzakis A; Miller J
    Transplantation; 1996 Oct; 62(8):1149-60. PubMed ID: 8900317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice.
    Smith JP; Kasten-Jolly J; Field LJ; Thomas JM
    Transplantation; 1994 Aug; 58(3):324-9. PubMed ID: 8053056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation.
    Mathew JM; Carreno M; Fuller L; Ricordi C; Kenyon N; Tzakis AG; Miller J; Esquenazi V
    Transplantation; 1999 Oct; 68(8):1172-80. PubMed ID: 10551647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation.
    Mathew JM; Carreno M; Fuller L; Burke GW; Ciancio G; Ricordi C; Tzakis AG; Esquenazi V; Miller J
    Transplantation; 2002 Sep; 74(6):846-55. PubMed ID: 12364866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of donor-specific bone marrow cell infusion on chimerism and acute rejection in kidney transplantation].
    Fu YW; Wang WG; Zhou HL; Zhang WL; Yang SJ; Wang JG
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1983-5. PubMed ID: 15730811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of allogeneic bone marrow labeled with neomycin resistance gene to examine bone marrow-derived chimerism in experimental organ transplantation.
    Smith JP; Kasten-Jolly J; Rebellato L; Haisch CE; Thomas JM
    Cell Transplant; 1997; 6(4):369-76. PubMed ID: 9258510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.
    Thomas JM; Carver FM; Cunningham PR; Olson LC; Thomas FT
    Transplantation; 1991 Jan; 51(1):198-207. PubMed ID: 1824804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation.
    Mathew JM; Carreno M; Zucker K; Fuller L; Kenyon N; Esquenazi V; Ricordi C; Tzakis AG; Miller J
    Transplantation; 1998 Apr; 65(7):947-55. PubMed ID: 9565100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
    Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
    Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.
    Corry RJ; Chakrabarti PK; Shapiro R; Rao AS; Dvorchik I; Jordan ML; Scantlebury VP; Vivas CA; Fung JJ; Starzl TE
    Ann Surg; 1999 Sep; 230(3):372-9; discussion 379-81. PubMed ID: 10493484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.